Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04378881
Previous Study | Return to List | Next Study

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04378881
Recruitment Status : Enrolling by invitation
First Posted : May 7, 2020
Last Update Posted : December 27, 2021
Sponsor:
Collaborator:
Cambia Health Solutions
Information provided by (Responsible Party):
Tabula Rasa HealthCare

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : April 30, 2022